We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Artisan Partners
APAM
$2.79B
| $817K | 0.01% |
29,670
-27,858
| -48% | -$742K |
|
|
STEL
677
DELISTED
Stellar Bancorp
STEL
| $815K | 0.01% |
28,979
+14,327
| +98% | +$424K |
|
678
Voyager Therapeutics
VYGR
$187M
| $815K | 0.01% |
29,940
-28,205
| -49% | -$645K |
|
679
Heritage Financial
HFWA
$1.24B
| $810K | 0.01% |
27,430
+2,908
| +12% | +$87.6K |
|
|
NLSN
680
DELISTED
Nielsen Holdings plc
NLSN
| $802K | 0.01% |
35,500
-900
| -2% | -$21.8K |
|
681
Gen Digital
GEN
$15.6B
| $800K | 0.01% |
36,780
-1,029,926
| -97% | -$22.1M |
|
682
Exelon
EXC
$48.6B
| $784K | 0.01% |
22,937
-785
| -3% | -$27.7K |
|
|
GTY
683
Getty Realty Corp
GTY
$2.1B
| $770K | 0.01% |
25,034
+6,910
| +38% | +$220K |
|
|
PVLA
684
Palvella Therapeutics
PVLA
$1.98B
| $758K | 0.01% |
2,016
-82
| -4% | -$24.5K |
|
685
Akebia Therapeutics
AKBA
$327M
| $738K | 0.01% |
152,461
-485,099
| -76% | -$2.76M |
|
|
FBC
686
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $736K | 0.01% |
22,222
+3,830
| +21% | +$128K |
|
687
Bankunited
BKU
$3.38B
| $734K | 0.01% |
+21,750
| New | +$750K |
|
|
ALDR
688
DELISTED
Alder Biopharmaceuticals
ALDR
| $732K | 0.01% |
62,225
-23,400
| -27% | -$283K |
|
689
CEVA Inc
CEVA
$1.01B
| $731K | 0.01% |
30,026
-100
| -0.3% | -$2.46K |
|
690
Capital City Bank Group
CCBG
$882M
| $724K | 0.01% |
29,117
+2,903
| +11% | +$68.2K |
|
|
MRLN
691
DELISTED
Marlin Business Services Corp
MRLN
| $719K | 0.01% |
28,834
-2,287
| -7% | -$51.5K |
|
692
Cushman & Wakefield Ltd
CWK
$2.98B
| $706K | 0.01% |
39,500
-74,139
| -65% | -$1.35M |
|
693
MGIC Investment
MTG
$6.27B
| $706K | 0.01% |
+53,700
| New | +$746K |
|
|
NPTN
694
DELISTED
NEOPHOTONICS CORP
NPTN
| $704K | 0.01% |
168,430
+17,630
| +12% | +$92.9K |
|
695
Trane Technologies
TT
$106B
| $690K | 0.01% |
5,450
-66,700
| -92% | -$7.98M |
|
696
VYNE Therapeutics
VYNE
$340K
| $684K | 0.01% |
1,585
+128
| +9% | +$63.3K |
|
697
CNO Financial Group
CNO
$4.97B
| $678K | 0.01% |
40,674
-149,552
| -79% | -$2.47M |
|
698
Idacorp
IDA
$8.23B
| $678K | 0.01% |
6,750
| – | – |
|
699
Walmart Inc
WMT
$871B
| $678K | 0.01% |
18,420
-4,380
| -19% | -$151K |
|
|
CWBC
700
Community West Bancshares
CWBC
$678M
| $676K | 0.01% |
31,488
+4,032
| +15% | +$80.4K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.